Account
Inquiry
Tirzepatide is a novel dual GIP and GLP-1 receptor agonist developed for type 2 diabetes research. Our pharmaceutical grade Tirzepatide offers 99% purity and is available in various vial sizes to meet different research requirements.
The compound works by activating both the GLP-1 and GIP receptors, which are important regulators of insulin secretion and glucose metabolism. This dual mechanism makes Tirzepatide particularly interesting for metabolic disorder research.
Our competitive Tirzepatide UK price makes this research compound accessible to laboratories and institutions. The product is supplied in lyophilized powder form with detailed analytical documentation.
For researchers investigating new approaches to diabetes treatment and metabolic regulation, our high-quality Tirzepatide offers reliable performance with batch-to-batch consistency.
Note: This product is for research use only, not for human consumption. Proper handling procedures should be followed when working with this compound in laboratory settings.
